EFS
ABMD

Essex Financial Services’s Abiomed Inc ABMD Stock Holding History

Essex Financial Services’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-631
Closed -$209K – 531
2022
Q1 		$209K Hold
631
– – 0.02% 470
2021
Q4 		$227K Hold
631
– – 0.02% 444
2021
Q3 		$205K Buy
+631
New +$214K 0.02% 439
2018
Q4 		– Sell
-500
Closed -$225K – 302
2018
Q3 		$225K Buy
+500
New +$197K 0.05% 258

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Essex Financial Services's ABMD Position: Q2 2022 in Review

Essex Financial Services sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 631 shares — an estimated $209K sold.

Essex Financial Services first reported a position in ABMD in Q3 2018 and held it in 4 quarters. The position peaked at $227K in Q4 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Essex Financial Services reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Essex Financial Services sold 631 Abiomed Inc shares in Q2 2022, an estimated $209K.
  • Essex Financial Services first reported a position in Abiomed Inc in Q3 2018 and held it in 4 quarters.
  • Essex Financial Services's Abiomed Inc position peaked at $227K in Q4 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Essex Financial Services's 13F filing for Q2 2022, filed 1 Aug 2022.